Global Meningitis Vaccine Market Report By Vaccine Type (Haemophilus Influenza Type B Vaccine, Pneumococcal Conjugate Vaccine, Pneumococcal Polysaccharide Vaccine, Meningococcal Vaccine, Others), By End-User (Adults and Children), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Others) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2021-2028

Name: Global Meningitis Vaccine Market Report
Brand: Value Market Research
SKU: Pharmaceuticals
Price: 3950.00 USD
Availability: OnlineOnly
Rating: 4.2 (80 reviews)

ID:VMR11213048

April 2021

Report Formats: Electronic (PDF), MS EXCEL

Description
Table Of Content

The global demand for Meningitis Vaccine Market is presumed to reach the valuation of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% during the period of 2022-2028.

Meningitis vaccine is a vaccine targeted towards teenagers and adults to protect them from meningococcal disease, dangerous inflammation affecting the lining of the brain, and spinal cord. Meningitis causes permanent damage like hearing loss, learning delays, the loss of fingers or toes, brain damage, and even death. This disease can be caused by bacteria, fungi, or a virus. Meningitis vaccine is prescribed for a meningococcal disease affecting kids, adults, military recruits, and people with a damaged or missing spleen and certain immune system disorders. The symptoms of meningitis include nausea, vomiting, altered mental status, and photophobia.

Market Dynamics

An increase in the occurrences of meningitis in preteens and teens is the main driver for the growth of the meningitis vaccine market. Growing awareness about immunization programs among the global population and the risk of permanent disability in kids affected by meningitis will stimulate market growth. The inclusion of the vaccine in the routine national immunization schedules will propel the market growth. An increase in global healthcare investments and the research and development of new vaccines targeting microbial outbreaks will be a market booster. The main challenges faced by the meningitis vaccine market are stringent government regulations for vaccine approval and low awareness related to the harmful effects of meningitis among the global population.

The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.

Additionally, these tools also give inclusive assessment of each application/product segment in the global market of meningitis vaccine.

Market Segmentation

The entire meningitis vaccine market has been sub-categorized into vaccine type, end-user and distribution channel. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.

By Vaccine Type

Haemophilus Influenza Type B Vaccine
Pneumococcal Conjugate Vaccine
Pneumococcal Polysaccharide Vaccine
Meningococcal Vaccine
Others

By End-User

Adults and children

By Distribution Channel

Hospital Pharmacies
Retail Pharmacies
Others

Regional Analysis

This section covers regional segmentation which accentuates on current and future demand for meningitis vaccine market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.

Global Meningitis Vaccine Market Share by Region (Representative Graph)

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the meningitis vaccine market include GlaxoSmithKline, plc, Pfizer, Inc., Merck & Co., Inc., Sanofi Pasteur SA, Astellas Pharma Inc., CSL Limited, Emergent BioSolutions, Inc., Johnson & Johnson, MedImmune, LLC, Serum Institute of India Pvt. Ltd., Bavarian Nordic, Mitsubishi Tanabe Pharma Corporation, Protein Sciences Corporation, Panacea Biotec. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY
       2.1. Highlights of Meningitis Vaccine Market
       2.2. Global Meningitis Vaccine Market Snapshot

3 . MENINGITIS VACCINE – INDUSTRY ANALYSIS
       3.1. Introduction
       3.2. Market Drivers of Meningitis Vaccine Market
       3.3. Market Restraints of Meningitis Vaccine Market
       3.4. Opportunities of Meningitis Vaccine Market
       3.5. Trends of Meningitis Vaccine Market
       3.6. Porter’s Five Force Analysis of Meningitis Vaccine Market
       3.7. Meningitis Vaccine Market Attractiveness Analysis
           3.7.1 Market Attractive Analysis by Vaccine Type
           3.7.2 Market Attractive Analysis by End-User
           3.7.3 Market Attractive Analysis by Distribution Channel
           3.7.4 Market Attractive Analysis by Region

4 . VALUE CHAIN ANALYSIS
       4.1. Meningitis Vaccine Value Chain Analysis
       4.2. Meningitis Vaccine Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Meningitis Vaccine Raw Material Manufactures List
           4.2.3. Price Trend of Meningitis Vaccine Key Raw Materials
     4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend

5 IMPACT ANALYSIS OF COVID-19 OUTBREAK
       5.1. Impact Analysis of Covid-19 Outbreak on Meningitis Vaccine Market
           5.1.1. Direct Impact on Production
           5.1.2. Supply Chain and Market Disruption
           5.1.3. Financial Impact on Firms and Financial Markets
       5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       5.3. Meningitis Vaccine Market: Pre V/S Post COVID-19
       5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Meningitis Vaccine Market Size in 2020, by Scenario
       5.5. COVID-19: Micro and Macro Factor Analysis on Meningitis Vaccine Market

6 . GLOBAL MENINGITIS VACCINE MARKET ANALYSIS BY VACCINE TYPE
       6.1 Overview by Vaccine Type
       6.2 Historical Data 2015-2018
       6.3 Global Meningitis Vaccine Market Analysis by Vaccine Type
       6.4 Market Analysis of Haemophilus Influenza Type B Vaccine by Regions
       6.6 Market Analysis of Pneumococcal Conjugate Vaccine by Regions
       6.5 Market Analysis of Pneumococcal Polysaccharide Vaccine by Regions
       6.7 Market Analysis of Meningococcal Vaccine by Regions
       6.8 Market Analysis of Others by Regions

7 . GLOBAL MENINGITIS VACCINE MARKET ANALYSIS BY END-USER
       7.1 Overview by End-User
       7.2 Historical Data 2015-2018
     7.3 Global Meningitis Vaccine Market Analysis by End-User
       7.4 Market Analysis of Adults and children by Regions

8 . GLOBAL MENINGITIS VACCINE MARKET ANALYSIS BY DISTRIBUTION CHANNEL
       8.1 Overview by Distribution Channel
       8.2 Historical Data 2015-2018
       8.3 Global Meningitis Vaccine Market Analysis by Distribution Channel
       8.4 Market Analysis of Hospital Pharmacies by Regions
       8.5 Market Analysis of Retail Pharmacies by Regions
       8.6 Market Analysis of Others by Regions

9 . GLOBAL MENINGITIS VACCINE MARKET ANALYSIS BY GEOGRAPHY
       9.1. Regional Outlook
       9.2. Introduction
       9.3. North America
           9.3.1. Overview and Historic Data
           9.3.2. North America Meningitis Vaccine Market Estimate By Market Segment
           9.3.3. North America Meningitis Vaccine Market Estimate By Country
           9.3.4. United State
           9.3.5. Canada
           9.3.6. Mexico
       9.4. Europe
           9.4.1. Overview and Historic Data
           9.4.2. Europe Meningitis Vaccine Market Estimate by Market Segment
           9.4.3. Europe Meningitis Vaccine Market Estimate by Country
           9.4.4. United Kingdom
           9.4.5. France
           9.4.6. Germany
           9.4.7. Italy
           9.4.8. Russia
           9.4.9. Rest Of Europe
       9.5. Asia Pacific
           9.5.1. Overview and Historic Data
           9.5.2. Asia Pacific Meningitis Vaccine Market Estimate by Market Segment
          9.5.3. Asia Pacific Meningitis Vaccine Market Estimate by Country
           9.5.4. China
           9.5.5. India
           9.5.6. Japan
           9.5.7. South Korea
           9.5.8. Australia
           9.5.9. Rest Of Asia Pacific
       9.6. Latin America
           9.6.1. Overview and Historic Data
           9.6.2. Latin America Meningitis Vaccine Market Estimate by Market Segment
           9.6.3. Latin America Meningitis Vaccine Market Estimate by Country
           9.6.4. Brazil
           9.6.5. Argentina
           9.6.6. Peru
           9.6.7. Chile
           9.6.8. Rest of Latin America
       9.7. Middle East & Africa
           9.7.1. Overview and Historic Data
           9.7.2. Middle East & Africa Meningitis Vaccine Market Estimate by Market Segment
           9.7.3. Middle East & Africa Meningitis Vaccine Market Estimate by Country
           9.7.4. Saudi Arabia
           9.7.5. UAE
           9.7.6. Israel
           9.7.7. South Africa
           9.7.8. Rest Of Middle East And Africa

10 . COMPETITIVE LANDSCAPE OF THE MENINGITIS VACCINE COMPANIES
       10.1. Meningitis Vaccine Market Competition
       10.2. Partnership/Collaboration/Agreement
       10.3. Merger And Acquisitions
       10.4. New Product Launch
       10.5. Other Developments

11 . COMPANY PROFILES OF MENINGITIS VACCINE INDUSTRY
       11.1. Company Share Analysis
       11.2. Market Concentration Rate
       11.3. GlaxoSmithKline, plc
           11.3.1. Company Overview
           11.3.2. Financials
           11.3.3. Products
           11.3.4. Recent Developments
       11.4. Pfizer, Inc.
           11.4.1. Company Overview
           11.4.2. Financials
           11.4.3. Products
           11.4.4. Recent Developments
       11.5. Merck & Co., Inc.
           11.5.1. Company Overview
           11.5.2. Financials
           11.5.3. Products
           11.5.4. Recent Developments
       11.6. Sanofi Pasteur SA
           11.6.1. Company Overview
           11.6.2. Financials
           11.6.3. Products
           11.6.4. Recent Developments
       11.7. Astellas Pharma Inc.
           11.7.1. Company Overview
           11.7.2. Financials
           11.7.3. Products
           11.7.4. Recent Developments
       11.8. CSL Limited
           11.8.1. Company Overview
           11.8.2. Financials
           11.8.3. Products
           11.8.4. Recent Developments
       11.9. Emergent BioSolutions, Inc.
           11.9.1. Company Overview
           11.9.2. Financials
           11.9.3. Products
           11.9.4. Recent Developments
       11.10. Johnson & Johnson
           11.10.1. Company Overview
           11.10.2. Financials
           11.10.3. Products
           11.10.4. Recent Developments
       11.11. MedImmune, LLC
           11.11.1. Company Overview
           11.11.2. Financials
           11.11.3. Products
           11.11.4. Recent Developments
       11.12. Serum Institute of India Pvt. Ltd.
           11.12.1. Company Overview
           11.12.2. Financials
           11.12.3. Products
           11.12.4. Recent Developments
       11.13. Bavarian Nordic
           11.13.1. Company Overview
           11.13.2. Financials
           11.13.3. Products
           11.13.4. Recent Developments
       11.14. Mitsubishi Tanabe Pharma Corporation
           11.14.1. Company Overview
           11.14.2. Financials
           11.14.3. Products
           11.14.4. Recent Developments
       11.15. Protein Sciences Corporation
           11.15.1. Company Overview
           11.15.2. Financials
           11.15.3. Products
           11.15.4. Recent Developments
       11.16. Panacea Biotec
           11.16.1. Company Overview
           11.16.2. Financials
           11.16.3. Products
           11.16.4. Recent Developments

*Note - In company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

LIST OF FIGURES

Research Scope of Meningitis Vaccine Report
Market Research Process
Market Research Methodology
Global Meningitis Vaccine Market Size, by Region (2019)
Porters Five Forces Analysis
Market Attractiveness Analysis by Vaccine Type
Market Attractiveness Analysis by End-User
Market Attractiveness Analysis by Distribution Channel
Market Attractiveness Analysis by Region
Value Chain Analysis
Global Meningitis Vaccine Market Analysis by Vaccine Type
Global Meningitis Vaccine Market Analysis in Haemophilus Influenza Type B Vaccine by Region
Global Meningitis Vaccine Market Analysis in Pneumococcal Conjugate Vaccine by Region
Global Meningitis Vaccine Market Analysis in Pneumococcal Polysaccharide Vaccine by Region
Global Meningitis Vaccine Market Analysis in Meningococcal Vaccine by Region
Global Meningitis Vaccine Market Analysis in Others by Region
Global Meningitis Vaccine Market Analysis by End-User
Global Meningitis Vaccine Market Analysis in Adults and children by Region
Global Meningitis Vaccine Market Analysis by Distribution Channel
Global Meningitis Vaccine Market Analysis in Hospital Pharmacies by Region
Global Meningitis Vaccine Market Analysis in Retail Pharmacies by Region
Global Meningitis Vaccine Market Analysis in Others by Region
Global Meningitis Vaccine Market by Revenue
North America Meningitis Vaccine Market by Revenue
Europe Meningitis Vaccine Market by Revenue
Asia Pacific Meningitis Vaccine Market by Revenue
Latin America Meningitis Vaccine Market by Revenue
Middle East & Africa Meningitis Vaccine Market by Revenue
Recent Development in Meningitis Vaccine Industry
Company Market Share Analysis

* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Choose your Buying Option

Single User License: $ 3950.00

Upto 10 Users License: $ 4950.00

Enterprise License: $ 8600.00

Data Pack: $ 2100.00

Buy Now

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

Buy sections of this report
Buy country level reports
Request for historical data
Request discounts available for Start-Ups & Universities

Request for Special Pricing

Objectives of Study

Define and measure the global market
Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
Analyze and identify major market trends along with the factors driving or inhibiting the market growth
Study the company profiles of the major market players with their market share
Analyze competitive developments

Why Choose Us

Client First Policy

Excellent Quality

After Sales Support

24/7 Email Support

Clients

Testimonials

" Doing business with Value Market Research was – quick, easy and accurate. We got what we expected. The team was very helpful and processes were altered for our convenience. The whole process from understanding our niche requirements to delivery to after sales was excellent. "

Vincenzo Baydar – Head Planning, Leading Food Chain, US

" Excellent work!! Working with you has been easy and direct. Your flexibility to alter the report scope and timely delivery assisted me in delivering my project proposal on time. "

Mia Tang, Director - Business Strategy, Steel Industry, Germany

" This is our second purchase and we have been obliged by the service. We appreciate the efforts put by Value Market Research in terms of understanding our needs, expanding the scope of the study, delivery and handling after sales queries. "